This is a demo store. No orders will be fulfilled.

Life Sciences

Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas

The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.

Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.

The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.

We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.

We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.

  1. Given the importance of the changes from PPACA and the creation of the health insurance marketplaces, we are providing our online Frost.com blog on HIX in collected form for the month of September for ease of use by our subscription clients. This discussion is brought to you by our Connected Health research program. Please also follow our blog, par...

    $450.00
  2. 30 Sep 2013  |  North America  |  Market Research

    Vital Signs - The Global Market for Type 2 Diabetes Therapeutics

    This issue of Vital Signs, released on September 30, 2013, provides a market overview and drug pipeline analysis of Type 2 diabetes therapeutics. Additionally, a company spotlight is provided for Trovagene in San Diego, CA. The company has a proprietary transrenal nucleic acid platform with the potential to deliver superior molecular diagnostics i...

    $450.00
  3. 30 Sep 2013  |  North America  |  Market Research

    Vital Signs - Healthcare News - The Analysts Perspective September 2013 Issue

    This issue of Vital Signs, released on September 30, 2013, discusses perspectives of different Frost & Sullivan analysts on recent noteworthy news items for various markets including Pharma/Biotech, In Vitro Diagnostics, Advanced Medical Technology and Connected Health.

    $450.00
  4. 26 Sep 2013  |  North America  |  Market Research

    US Medical Radiopharmaceuticals Market

    New Growth Opportunities Emerge in a Strenuous Market

    This research service pertains to the US market for medical radiopharmaceuticals. A thorough market sizing and forecasting model of market revenue, procedure volumes, and average pricing is included, along with analyses of market trends, drivers and restraints, and the reimbursement and the competitive environments at the total level as well as wit...

    $4,950.00
  5. 24 Sep 2013  |  Europe  |  Market Research

    Analysis of the Western and Eastern European Image and Information Management Systems Market

    Assessing the Trends and Dynamics of the RIS/PACS Market

    The research service is to provide an in-depth analysis of the European Image and Information Management Systems markets. It analyses the revenue potential, market dynamics and trends across Eastern Europe and Western Europe. The European Image and Information Management Systems.

    $4,950.00
  6. 23 Sep 2013  |  Europe  |  Market Research

    Analysis of the European Refurbished Medical Imaging Equipment Market

    Trends and Dynamics in the Used or Pre-owned Medical Imaging Systems Market

    This research service provides an in-depth analysis of the European refurbished medical imaging equipment market. It analyses the revenue potential, market dynamics, and trends across countries in Central and Eastern Europe and Western Europe as a combined European market. The revenue of the European refurbished medical imaging equipment market has...

    $4,950.00
  7. 23 Sep 2013  |  Asia Pacific  |  Market Research

    Analysis of the Global Type 2 Diabetes Therapeutics Market

    Market Opportunities for Differentiated Therapeutics

    The packaging industry plays a major role in the pharmaceutical market. It not only provides containment and drug safety, but also ensures identity, convenience of handling, and delivery. It needs to balance complex considerations. Pharmaceutical packaging firms are some of the industrys most innovative companies, as has been evident in the last 1...

    $10,000.00
  8. Given the importance of the changes from PPACA and the creation of the health insurance marketplaces, we are providing our online Frost.com blog on HIX in collected form for the month of August for ease of use by our subscription clients. This discussion is brought to you by our Connected Health research program. Please also follow our blog, part o...

    $450.00
  9. 03 Sep 2013  |  Global  |  Technology Research

    Innovations in Allergy Treatment and Monitoring (Technical Insights)

    Therapy and Monitoring Advances Help Achieve Long-term Relief from Allergy

    The global human plasma-derived therapeutics market is expected to experience a surge in demand due to an increase in the awareness of diseases and therapeutic options. The plasma-derived therapeutics market is segmented into albumin, immunoglobulins, coagulation factors, and other haemotologicals. The segments are discussed with supporting informa...

    $4,950.00
  10. 02 Sep 2013  |  North America  |  Customer Research

    Global Analysis of MicroRNA Tools and Services Market

    Evolving microRNA Market Provides an Opportunity for Vendors of qRT-PCR and Functional Tools

    The overall research objective was to capture and analyze global next-generation (NGS) sequencing trends and use. Most researchers outsource NGS technologies; however, in-house NGS technology use is expected to increase within the next 12 months. Data accuracy and operating costs are the top criteria for purchasing sequencing instruments. Disease-r...

    $10,000.00